Novel model predicts prognosis for patients with diffuse large B-cell lymphoma in first relapse after initial R-CHOP therapy: a single-institution study in China.

Wei WangJingjing YinWei ZhangYan ZhangDaobin ZhouDanqing ZhaoChong Wei

Published in: The Journal of international medical research (2021)

TTR and B symptoms can be used as important predictors of survival in patients with DLBCL. The TLLB system provides a useful prognostic model compared with the previous TTL system.

Keyphrases

diffuse large b cell lymphoma
epstein barr virus
free survival
stem cells
depressive symptoms
mesenchymal stem cells
bone marrow